Conversely, the proteoglycans in cancer pathway, containing genes which code for matrix metalloproteinases (MMP), WNT signaling molecules, and growth factors such as IGF1 and FGF2, is prominent in bexarotene differential expression analysis but not MSU-42011. This evidence concerns the gene FGF2 and cancer.